Agenda for July 2022 PBAC meeting

1 April 2022 - 30 March 2022 - The agenda for the July 2022 PBAC meeting is now available. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 April 2022

1 April 2022 - The April 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

2022 April cycle - brand price reductions and savings to patients

31 March 2022 - Brand price reductions and savings to patients resulting from the 2022 April cycle of price disclosure have ...

Read more →

Government hopes to hook voters with cheaper drugs

29 March 2022 - Patients will get access to cheaper or free medicines sooner under plans to reduce the PBS ...

Read more →

Federal budget 2022: more funding for breast cancer drug Trodelvy

29 March 2022 - Against all the odds Sydney mum Alison Day will get to celebrate her daughter’s 12th birthday — ...

Read more →

Government fails to adequately address medicine affordability for working Australians

29 March 2022 - The cost of medicines will continue to go up unchecked as the Federal Government has failed ...

Read more →

Budget 2022-23 – no ‘big bang’ announcements in health

29 March 2022 - Medicines Australia welcomes tonight’s Budget announcements for new PBS listings and on-going COVID-19 measures. ...

Read more →

Record investment in the future of Australia's health system

29 March 2022 - The Australian Government is investing in a stronger health system as part of our plan for a ...

Read more →

Federal Budget vision must extend beyond election day to secure better long-term health for all Australians

28 March 2022 - Medicines Australia is hoping tomorrow’s Budget reveals a long-term vision for health with strong investments in ...

Read more →

Landmark PBS listing for Australians with cystic fibrosis

27 March 2022 - From April 1 2022, Trikafta (elexacaftor with tezacaftor and ivacaftor and ivacaftor) will be available on ...

Read more →

Expanded PBS listing for lung disease medication

25 March 2022 - The Australian Government is helping more Australians access the medications they need with a new addition to ...

Read more →

DUSC utilisation analysis public release documents

25 March 2022 - The utilisation analysis public release documents from the October 2021 DUSC meeting are now available. ...

Read more →

Government opts for additional consultation on National Medicines Policy review

24 March 2022 - The Government has heeded the calls from Medicines Australia, patient groups, health bodies, and industry by ...

Read more →

New Australian agency to accelerate genomic research and drive innovation in health care

21 March 2022 - Genomics advances will help develop revolutionary treatments for some of our biggest health challenges, including diagnosing ...

Read more →

Genomics Australia to guide the future of genomic health and medicine over the coming decade

21 March 2022 - Through our 10 year Medical Research Future Fund (MRFF) plan, the Morrison Government is committed to ...

Read more →